✦ LIBER ✦

Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study

✍ Scribed by del Ser, Teodoro ;Steinwachs, Klaus C. ;Gertz, Hermann J. ;Andrés, María V. ;Gómez-Carrillo, Belén ;Medina, Miguel ;Vericat, Joan A. ;Redondo, Pilar ;Fleet, David ;León, Teresa

Book ID: 120682211
Publisher: IOS Press
Year: 2012
Tongue: English
Weight: 229 KB
Volume: 33
Category: Article
ISSN: 1387-2877
DOI: 10.3233/JAD-2012-120805

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II randomized, double-blind, par

A phase II randomized, double-blind, parallel group, 26-week study of GSK-3 inhibitor tideglusib in Alzheimer's disease (ARGO trial)

✍ del Ser, Teodoro; Lovestone, Simon; Boada-Rovira, Mercè; Dubois, Bruno; Hüll, Mi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 219 KB

GSK-3 inhibitors and their potential in

GSK-3 inhibitors and their potential in the treatment of Alzheimer’s disease

✍ Kypta, Robert M 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 298 KB

[Topics in Medicinal Chemistry] Alzheime

[Topics in Medicinal Chemistry] Alzheimer's Disease Volume 2 || GSK-3 Inhibitors for the Treatment of Alzheimer's Disease

✍ Lau, Lit-Fui; Brodney, Michael A. 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg ⚖ 623 KB

A phase 2 trial of the GSK-3 inhibitor t

A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy

✍ Tolosa, Eduardo; Litvan, Irene; Höglinger, Günter U.; Burn, David; Lees, Andrew; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

P116 TAUROS: A clinical trial on Progres

P116 TAUROS: A clinical trial on Progressive Supranuclear Palsy with the GSK-3 inhibitor Tideglusib (Zentylor®)

✍ G. Höglinger; G. Respondek; M. Stamelou; A. Kupsch; A. Lipp; C. Noack; G. Ebersb 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 39 KB

Phase IIa clinical trial on Alzheimer's

Phase IIa clinical trial on Alzheimer's disease with NP12, a GSK3 inhibitor

✍ Teodoro del Ser 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB